Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events
- Conditions
- High Risk for Postoperative Cardiovascular Events
- Registration Number
- NCT01262222
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to look at a new method for finding out if patients have a risk of heart complications from surgery. At the present, to find out if patients have a risk of heart complications from surgery, look at whether the patient has heart disease, diabetes, kidney problems, and stroke. The investigators hope that this study will confirm a new, safe test to help us predict the risk of surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- Age 50 or older
- Undergoing High Risk Cancer Surgery (Patient must be undergoing one of the following procedures NOTE: All open or robotic forms of the following procedures meet the eligibility criteria. GMT/ Hepatobiliary
- Pancreatic Resection
- Retroperitoneal Sarcomas
- Shoulder (Forequarter) Amputation
- Esophagectomy, Esophagogastrectomy
- Pheochromocytoma
- Liver Resection (with or without Bile Duct Resection) Orthopedics
- Spine Resections (with or without Spinal Fusion)
- Metastatic Disease Requiring Total Hip Replacement
- Total Shoulder Replacement / Forequarter Amputation
- Hemipelvectomy
- Sacrectomy Thoracic
- Extrapleural Pneumonectomy
- Pleurectomy and Decortication
- Pneumonectomy
- Esophagogastrectomy
- Mediastinal Tumor Resection
- Pancoast Tumor
- Completion Pneumonectomy
- Lobectomy (post-induction chemotherapy; or severe COPD)
- Segmentectomy Colorectal/ GYN
- Colon Resection with possible Sacrectomy
- Pelvic Exenteration
- Advanced ovarian cancer resection with or without liver resection Urology
- Radical Cystectomy
- Open Radical Prostatectomy
- Nephrectomy with Vena Caval Resection Head & Neck
- Thyroid Resection with Mediastinal involvement
- Major head and neck cancer resection with Free Flap reconstruction Other
- Unclassified Major Surgery at the Discretion of the PI
- Postoperative stay likely to be 2 or more days
- Patients willing to tolerate inflation of a blood pressure cuff for 5 minutes
- Patients willing to cut long nails in order to wear finger probe.
- Patients with one or more of the following RCRI risk factors:
- History of ischemic heart disease (any)
- History of myocardial infarction
- History of positive exercise test
- Current complaint of chest pain considered secondary to myocardial ischemia
- Use of nitrate therapy
- ECG with pathological Q waves
- History of congestive heart failure (any)
- History of congestive heart failure
- Pulmonary edema
- Paroxysmal nocturnal dyspnea
- Bilateral rales or S3 gallop
- Chest radiograph showing pulmonary vascular redistribution
- History of cerebrovascular disease (any)
- History of transient ischemic attack (TIA) or stroke
- Preoperative treatment with insulin
- Preoperative serum creatinine > 2.0 mg/dL
- Evidence of peripheral vascular disease other than cerebral vascular disease (Although peripheral vascular disease is not strictly a RCRI risk factor, Fleisher indicates: "It would not be inappropriate to assume that any atherosclerotic class of disease is equivalent to ischemic heart disease for risk purposes."
- Medical conditions precluding use of arm blood pressure measurements such as prior lymphadenectomy, vascular shunts for dialysis or upper extremity occlusive vascular disease
- Patients undergoing emergency surgery
- Any of the following active conditions
- Unstable coronary syndromes
- Uncompensated heart failure; worsening or new onset CHF
- Significant arrhythmias
- Atrial fibrillation, presently
- High grade AV block
- Symptomatic ventricular arrhythmias or new ventricular arrhythmias
- Supraventricular arrhythmias with poor rate control
- Symptomatic bradycardia
- Severe valvular disease
- Severe aortic stenosis (mean transvalvular gradient >40mmHg)
- Symptomatic mitral stenosis
- Any other condition that at the judgment of the investigator might require additional evaluation and treatment before surgery.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine whether endothelial dysfunction as measured by abnormal flow mediated dilation (FMD). 1 year Identifies patients at high risk of cardiovascular complications after major thoracic or abdominal cancer surgery.
- Secondary Outcome Measures
Name Time Method To obtain preliminary information on whether abnormal FMD adds predictive information beyond risk algorithms 1 year proposed by the American Heart Association/American College of Cardiology.
To determine whether abnormal flow mediated dilation (FMD) correlates to abnormal brain natriuretic enzyme BNP levels prior to surgery. 1 year To survey whether FMD prior to surgery is affected by treatment with chemotherapy and/or radiation prior to major cancer surgery 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Cancer Center🇺🇸New York, New York, United States